ByHeart Update: FDA Confirms Review of ByHeart's Root Cause Investigation and Action Plan, Following Completion of Facility Inspections

FDA found no factors that could explain the cause of the outbreak in ByHeart facilities FDA responded with no further questions on ByHeart's investigation and Action Plan ByHeart introduces new C. botulinum testing protocols 1000x more sensitive than the standard industry test methodology...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.